Bone and Joint Healthcare

Bone and Joint Healthcare

Osteoarthritis

Osteoarthritis (OA) is a chronic, degenerative joint disease that primarily affects the cartilage — the smooth, slippery tissue that covers the ends of bones where they meet to form a joint. Over time, this cartilage breaks down, leading to friction between bones, inflammation and progressive joint damage. OA can affect any joint in the body, but it most commonly involves the knees, hips, hands, spine, and feet.


The disease progresses slowly over years, often beginning with mild stiffness or discomfort and gradually leading to significant pain, loss of movement, and functional limitation. Unlike inflammatory arthritis (such as rheumatoid arthritis), OA is non-systemic, meaning it primarily affects individual joints rather than the entire body

Osteoarthritis is one of the most prevalent musculoskeletal disorders worldwide, affecting an estimated 7–10% of the global population. According to the World Health Organization (WHO), approximately 528 million people were living with osteoarthritis in 2019, and this number continues to rise due to aging populations and increasing obesity rates.


• Women are affected more frequently than men, particularly after menopause, likely due to hormonal and anatomical differences.
• The knee is the most commonly affected joint, followed by the hip and hand.

• OA is more common in adults over 50 years old, but early-onset OA can occur after joint injuries or repeated physical stress.

• Osteoarthritis is a leading cause of disability, responsible for reduced mobility, loss of work productivity, and decreased quality of life.

Osteoarthritis results from a combination of mechanical, biological, and genetic factors that disturb the balance between cartilage breakdown and repair. Major contributors include:

1. Age: Cartilage loses its ability to repair with age, making joints more susceptible to wear and tear.
2. Genetics: Inherited factors influence cartilage structure and metabolism, increasing OA risk in some families.
3. Gender and Hormones: Women, especially postmenopausal women, are at greater risk, possibly due to estrogen decline.
4. Obesity: Excess body weight increases mechanical load on joints and promotes inflammation through adipokines.
5. Joint Injury or Overuse: Repetitive strain, sports injuries, or occupational stress can accelerate cartilage degeneration.
6. Muscle Weakness and Poor Alignment: Weak surrounding muscles or abnormal joint alignment (e.g., bow legs) increase stress on the joint.
7. Metabolic and Inflammatory Conditions: Diabetes, metabolic syndrome, and low-grade chronic inflammation can also play roles.

Osteoarthritis symptoms develop gradually and vary in intensity, depending on the joint and disease stage. Common signs include:

•Pain: Aching or deep discomfort that worsens with activity and improves with rest.
•Stiffness: Especially noticeable in the morning or after periods of inactivity (“gelling phenomenon”).
•Swelling: Mild joint swelling or inflammation due to synovial fluid changes.
•Limited Range of Motion: Reduced flexibility and difficulty moving the joint fully.
•Crepitus: A grating, clicking, or cracking sound during joint movement.
•Joint Deformity: In advanced cases, bone enlargement and misalignment may become visible.
•Functional Limitation: Difficulty walking, climbing stairs, gripping objects, or performing daily activities.

Diagnosis of osteoarthritis is based on clinical evaluation and diagnostic testing to confirm structural changes and exclude other causes of joint pain.


1. Clinical Assessment:

•Detailed medical history (symptom duration, injury history, family history)
•Physical examination (tenderness, swelling, range of motion, crepitus, deformity)

2. Imaging Tests:

•X-rays: Show joint space narrowing, bone spurs (osteophytes), and changes in bone shape.
•MRI (Magnetic Resonance Imaging): Detects early cartilage damage, synovitis, and soft tissue abnormalities.
•Ultrasound: Useful for assessing joint effusion and soft-tissue inflammation.

3. Laboratory Tests:

•Blood tests: To rule out inflammatory arthritis (e.g., rheumatoid arthritis).
•Joint fluid analysis: Checks for inflammation or crystals (in cases where gout or infection is suspected)

Although osteoarthritis cannot currently be cured, a comprehensive treatment plan can effectively relieve pain, slow disease progression, and improve joint function. Management is often tailored to the patient’s age, disease severity, affected joints, and lifestyle.

1. Lifestyle and Non-Pharmacological Management Weight management: Even modest weight loss significantly reduces pressure on weight-bearing joints such as the knees and hips. Physical activity: Regular, low-impact exercises like swimming, cycling, or yoga help strengthen supporting muscles, maintain flexibility, and reduce stiffness. Physiotherapy: Guided exercises and manual therapy improve joint alignment and mobility. Assistive devices: Orthotic supports, braces, or walking aids relieve joint load and enhance stability. Patient education: Empowering patients to understand the condition and adopt self-management strategies improves long-term outcomes

2. Pharmacological Therapy

Pharmacological management focuses on symptom relief and protection of joint structures. It may include:

•Analgesics: Paracetamol (acetaminophen) for mild to moderate pain.
•Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Used to control pain and inflammation; available in oral and topical forms.
•Topical agents: Capsaicin or diclofenac gels for localized pain relief.
•Intra-articular injections: Corticosteroids to reduce acute inflammation or hyaluronic acid to improve joint lubrication and elasticity

3. The Chondroprotective Approach

In recent years, there has been growing interest in chondroprotective therapy, which aims not only to relieve symptoms but also to protect and preserve cartilage structure and function.

Chondroprotective agents work by nourishing cartilage, enhancing joint metabolism, reducing inflammation, and slowing degenerative changes. They are often used as part of long-term management strategies, especially in early and moderate stages of osteoarthritis.

Commonly used chondroprotective substances include:

•Glucosamine sulfate and Glucosamine hydrochloride: Stimulate cartilage cell activity and support the synthesis of glycosaminoglycans, essential components of joint cartilage.
•Chondroitin sulfate: Helps retain water in cartilage tissue, improving elasticity and shock absorption.
•Hyaluronic acid (oral or injectable): Enhances joint lubrication and reduces friction during movement.
•Collagen hydrolysate: Provides amino acids necessary for cartilage matrix formation and repair.
•Diacerein: A slow-acting agent that modulates inflammatory cytokines and supports cartilage homeostasis.
•Avocado-soybean unsaponifiable (ASU): Natural extracts shown to inhibit inflammatory mediators and stimulate cartilage repair.

Benefits of chondroprotective therapy:

•May slow structural progression of osteoarthritis.
•Provides sustained symptom relief with long-term use.
•Often well tolerated and suitable for chronic administration.
•Can be used in combination with physical therapy and standard pharmacologic agents

4. Surgical Interventions

When conservative treatments fail to control pain or maintain function, surgery may be indicated

Arthroscopy: Minimally invasive cleaning or smoothing of damaged cartilage (limited indications).

Osteotomy: Realignment of bones to redistribute load on the joint.

Joint replacement (arthroplasty): Replacement of the damaged joint surface with artificial components, typically in advanced OA cases.

Untreated or poorly managed osteoarthritis can lead to:

  • Chronic pain and disability
  • Muscle wasting and weakness
  • Joint deformity and instability
  • Increased risk of falls and fractures
  • Emotional and social impacts, including depression and reduced quality of life

Preventive strategies focus on protecting joint health throughout life:

  • Maintain a healthy body weight to reduce mechanical stress.
  • Engage in regular, moderate physical activity to strengthen muscles and support joints.
  • Avoid repetitive joint strain and overuse injuries.
  • Ensure adequate calcium, vitamin D, and omega-3 intake for bone and joint health.
  • Address posture, ergonomics, and workplace adjustments to minimize stress on joints.
  • Manage underlying conditions like diabetes or metabolic syndrome that can worsen OA progression

You should consult a healthcare professional if you experience:

  1. Persistent joint pain or stiffness lasting more than a few weeks
  2. Swelling or warmth around a joint
  3. Noticeable joint deformity or loss of function
  4. Difficulty performing daily activities (e.g., walking, climbing stairs, gripping)
  5. Sudden onset of severe pain, redness, or inability to move a joint — which may indicate another condition, such as gout or infection

  1. Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393(10182):1745–1759.
  2. Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3–25.
  3. Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010;26(3):355–369
  4. Kolasinski SL, et al. 2020 American College of Rheumatology Guideline for the Management of Osteoarthritis. Arthritis Care Res. 2020;72(2):149–162
  5. Martel-Pelletier J, et al. Osteoarthritis. Nat Rev Dis Primers. 2016;2:16072.Litwic A, et al. Epidemiology and burden of osteoarthritis. Br Med Bull. 2013;105:185–199.Roman-Blas JA, et al. Chondroitin sulfate and glucosamine in OA: mechanisms and evidence. Osteoarthritis Cartilage. 2009;17 Suppl 1:S1–S3.
  6. Henrotin Y, Martel-Pelletier J, et al. The chondroprotective concept in osteoarthritis. Joint Bone Spine. 2017;84(2):125–130.
  7. Hochberg MC, et al. Role of nutraceuticals and chondroprotection. Am J Med. 2016;129(9):S33–S37.